{"entity":{"id":"pilar-garrido","kind":"person","name":"Pilar Garrido","aka":[],"tldr":"Pilar Garrido is a thoracic oncologist and past president of the Spanish Society of Medical Oncology.","summary":"Pilar Garrido is Head of Medical Oncology at Hospital Universitario Ramón y Cajal in Madrid, Professor at the Universidad de Alcalá and a former Council member of the European Society for Medical Oncology (ESMO). A thoracic oncologist, her specialisms are lung cancer, precision oncology and health policy, and she is a past president of the Spanish Society of Medical Oncology. Her papers include the Spanish Lung Cancer Group Trial 9901 on complete resection after induction chemotherapy in stage III non-small-cell lung cancer, a JAMA Oncology study of the Lung Immune Prognostic Index and immune checkpoint inhibitor outcomes, and the Spanish national consensus on predictive biomarker testing in advanced non-small-cell lung cancer. Her publications are listed on PubMed.","asOf":"2026-09-08","links":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Garrido%20P%5BAuthor%5D%20lung%20cancer"}],"tags":[],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["esmo"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["clinical-and-translational-oncology"],"dependsOn":[],"notes":[],"role":"Head of Medical Oncology, Hospital Universitario Ramón y Cajal; Professor, Universidad de Alcalá; former ESMO Council member","institutionId":"esmo","specialisms":["Lung cancer","Precision oncology","Health policy"],"profiles":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Garrido%20P%5BAuthor%5D%20lung%20cancer"}],"papers":[{"title":"Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901","journal":"Journal of Clinical Oncology","year":2007,"doi":"10.1200/jco.2007.12.0014"},{"title":"Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer","journal":"JAMA Oncology","year":2018,"doi":"10.1001/jamaoncol.2017.4771"},{"title":"Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology","journal":"Clinical and Translational Oncology","year":2019,"doi":"10.1007/s12094-019-02218-4"}]},"route":"/people/pilar-garrido/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"institution":[{"id":"esmo","kind":"institution","name":"European Society for Medical Oncology (ESMO)","route":"/institutions/esmo/"}],"journal":[{"id":"clinical-and-translational-oncology","kind":"journal","name":"Clinical & translational oncology","route":"/journals/clinical-and-translational-oncology/"}]}}